Related Experiment Video
Updated: Mar 19, 2026
Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro
Published on: March 18, 2014
Silver nanoparticles defeat p53-positive and p53-negative osteosarcoma cells by triggering mitochondrial stress and
Dávid Kovács1, Nóra Igaz1, Csilla Keskeny1
1Department of Biochemistry and Molecular Biology, University of Szeged, Középfasor 52, H-6726, Szeged, Hungary.
Abstract:
Loss of function of the tumour suppressor p53 observed frequently in human cancers challenges the drug-induced apoptotic elimination of cancer cells from the body. This phenomenon is a major concern and provides much of the impetus for current attempts to develop a new generation of anticancer drugs capable of provoking apoptosis in a p53-independent manner. Since silver nanoparticles (AgNPs) possess unique cytotoxic features, we examined, whether their activity could be exploited to kill tumour suppressor-deficient cancer cells. Therefore, we investigated the effects of AgNPs on osteosarcoma cells of different p53 genetic backgrounds. As particle diameters might influence the molecular mechanisms leading to AgNP-induced cell death we applied 5 nm and 35 nm sized citrate-coated AgNPs. We found that both sized AgNPs targeted mitochondria and induced apoptosis in wild-type p53-containing U2Os and p53-deficient Saos-2 cells. According to our findings AgNPs are able to kill osteosarcoma cells independently from their actual p53 status and induce p53-independent cancer cell apoptosis. This feature renders AgNPs attractive candidates for novel chemotherapeutic approaches.
Insights
Silver nanoparticles (AgNPs) effectively induce cancer cell death independently of p53 status. These nanoparticles target mitochondria, triggering apoptosis and offering a promising avenue for novel cancer therapies.
Area of Science:
- Nanotechnology
- Cancer Biology
- Biomedical Engineering
Background:
- Loss of function of the tumour suppressor p53 is common in human cancers, hindering conventional chemotherapy.
- Developing p53-independent cancer treatments is crucial for effective tumor elimination.
- Silver nanoparticles (AgNPs) exhibit cytotoxic properties that may be leveraged against cancer cells.
Purpose of the Study:
- To investigate the efficacy of silver nanoparticles (AgNPs) in inducing apoptosis in osteosarcoma cells with varying p53 genetic backgrounds.
- To determine if AgNP-induced cell death is dependent on the p53 status of cancer cells.
- To explore the potential of AgNPs as a novel therapeutic agent for p53-deficient cancers.
Main Methods:
- Treatment of osteosarcoma cells (U2Os with wild-type p53 and Saos-2 with p53-deficient) with 5 nm and 35 nm citrate-coated AgNPs.
- Assessment of AgNP-induced apoptosis and mitochondrial targeting.
- Evaluation of cell death mechanisms in relation to p53 genetic status.
Main Results:
- Both 5 nm and 35 nm AgNPs induced apoptosis in osteosarcoma cells, irrespective of their p53 status.
- AgNPs were found to target mitochondria, initiating the apoptotic cascade.
- The cytotoxic effects of AgNPs on osteosarcoma cells were independent of p53 functionality.
Conclusions:
- Silver nanoparticles demonstrate significant potential for inducing cancer cell apoptosis in a p53-independent manner.
- AgNPs represent a promising candidate for developing next-generation chemotherapeutic strategies, particularly for p53-deficient tumors.
- The findings support the exploration of AgNPs in novel anticancer drug development.
